Immunology of atherosclerosis

Thrombosis and Haemostasis

Volumn 106, Issue 5, 2011, Pages 755-756

  Lutgens, Esther ^a,b   Binder, Christoph J ^c,d  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

^d ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M ANTIBODY;

ATHEROGENESIS; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; B LYMPHOCYTE; CHRONIC INFLAMMATION; EDITORIAL; HUMAN; IMMUNOLOGY; MACROPHAGE; MONOCYTE; NATURAL KILLER CELL; PHAGOCYTOSIS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE;

ANIMALS; ARTERIES; ATHEROSCLEROSIS; HUMANS; INFLAMMATION;

EID: 80155125090     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH11-10-0683     Document Type: Editorial

References (25)

1. Virchow R. Cellular pathology as based upon physiological and pathological history. Classics of Medicine library, Birmingham, Alabama, 1958.
2. Ross R, Glomset JA. Atherosclerosis and the arterial smooth muscle cell. Science 1973; 180: 1332-1339.
3. Ross R. Atherosclerosis- an inflammatory disease. N Engl J Med 1999; 340: 115-126.
4. Yan ZQ, Hansson GL. innate immunity, macrophage activation and atherosclerosis. Immunol Rev 2007: 219: 187-203.
5. Charo IF, Ransohoff RM. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 2006; 354: 610-621.
6. Hansson GK, Libby P. The immune response in atherosclerosis: a double edged sword. Nat Rev Immunol 2006; 6: 508-519.
7. Weber C, Zernecke A, Libby P. The multifaceted contributions of leukocyte subsets in atherosclerosis. Nat Rev Immunol 2008; 8: 802-815.
8. Galkina E, Ley K. Immune and inflammatory mechanisms in atherosclerosis. Annu Rev Immunol 2009; 27: 165-197.
9. Lutgens E, Lievens D, Beckers L, et al. Deficient CD40-TRAF6 signaling in leukocytes prevents atherosclerosis by skewing the immune response toward an antiinflammatory profile. J Exp Med 2010; 207: 391-404.
10. Ait-Oufella H, Herbin O, Bouaziz JD, et al. B cell depletion reduces the development of atherosclerosis in mice. J Exp Med 2010; 207: 1579-1587.
11. Kyaw T, Tay C, Krishnamurthi S, et al. B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions. Circ Res 2011; 109: 830-840.
12. Chou MY, Fogelstrand L, Hartvigsen K, et al. Oxidation specific epitopes are dominant targets of innate natural antibodies in mice and humans. J Clin Invest 2009; 119: 1335-1349.
13. Hristov M, Weber C. Differential role of monocyte subsets in atherosclerosis. Thromb Haemost 2011; 106: 757-762.
14. Wolfs I, Donners M, de Winther M. Differentiation factors and cytokines in the atherosclerotic plaque micro-environment as a trigger for macrophage polarization. Thromb Haemost 2011; 106: 763-771.
15. Manthey H, Zernecke A. Dendritic cells in the pathogenesis of atherosclerosis: immune regulation and beyond. Thromb Haemost 2011; 106: 772-778.
16. Ketelhuth D, Hansson G. Cellular immunity, LDL and atherosclerosis: break of tolerance in the arthery wall. Thromb Haemost 2011; 106: 779-786.
17. Butcher M, Galkina E. Current view on the role of IL-17-producing cells in atherosclerosis. Thromb Haemost 2011; 106: 787-795.
18. de Jager SCA, Kuiper J. Vaccination strategies in atherosclerosis. Thromb Haemost 2011; 106: 796-803.
19. Gerdes N, Zirlik A. Costimulation - the Yin and Yang in atherosclerosis? Thromb Haemost 2011; 106: 804-813.
20. Getz G, Van der Laan P, Reardon C. Natural killer T cells in lipoprotein metabolism and atherosclerosis. Thromb Haemost 2011; 106: 814-819.
21. Bot I, Biessen E. Mast cells in atherosclerosis Thromb Haemost 2011; 106: 820-826.
22. Lievens D, von Hundelshausen P. Platelets in atherosclerosis. Thromb Haemost 2011; 106: 827-838.
23. Drechsler M, Döring Y, Megens RTA, et al. Neutrophilic granulocytes - promiscuous accelerators of atherosclerosis. Thromb Haemost 2011; 106: 839-848.
24. Wade NS, Major A. The problem of accelerated atherosclerosis in systemic lupus erythematosus: Insights into a complex co-morbidity. Thromb Haemost 2011; 106: 849-857.
25. Rosenfeld M, Campbell LA. Pathogens and Atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 2011; 106: 858-867.